Company attributes
B2X
0
Phone Number
Investors
No article content yet.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
3852.ai repurposes generic drugs into novel combination drug treatments for breast and ovarian cancer. 3852.ai combines predictive artificial intelligence and robotics to find these treatments quickly and economically.
